LAVA Therapeutics N.V. (LVTX)
NASDAQ: LVTX · Real-Time Price · USD
1.325
+0.015 (1.15%)
Jun 23, 2025, 4:00 PM - Market closed

LAVA Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Revenue
4.9911.986.7719.395.353.75
Upgrade
Revenue Growth (YoY)
-60.20%77.01%-65.09%262.45%42.78%-
Upgrade
Cost of Revenue
24.5524.5536.04--15.7
Upgrade
Gross Profit
-19.56-12.57-29.2719.395.35-11.95
Upgrade
Selling, General & Admin
13.2813.2314.1214.1212.022.72
Upgrade
Research & Development
-1.49--40.1136.95-
Upgrade
Operating Expenses
11.7913.2314.1254.2348.962.72
Upgrade
Operating Income
-31.35-25.79-43.39-34.84-43.61-14.67
Upgrade
Interest Expense
-0.51-0.52-0.47--0.63-0.34
Upgrade
Interest & Investment Income
3.53.763.670.26--
Upgrade
Currency Exchange Gain (Loss)
-0.141.97-1.422.922.04-0.87
Upgrade
EBT Excluding Unusual Items
-28.5-20.58-41.61-31.66-42.2-15.88
Upgrade
Merger & Restructuring Charges
-3.9-3.9----
Upgrade
Pretax Income
-27.2-24.48-41.61-31.66-42.2-15.88
Upgrade
Income Tax Expense
0.790.630.260.250.160.04
Upgrade
Net Income
-27.99-25.11-41.87-31.91-42.36-15.93
Upgrade
Net Income to Common
-27.99-25.11-41.87-31.91-42.36-15.93
Upgrade
Shares Outstanding (Basic)
27272726200
Upgrade
Shares Outstanding (Diluted)
27272726200
Upgrade
Shares Change (YoY)
0.00%0.38%3.12%31.21%4850.36%-10.81%
Upgrade
EPS (Basic)
-1.04-0.94-1.57-1.23-2.14-39.90
Upgrade
EPS (Diluted)
-1.04-0.94-1.57-1.23-2.14-39.90
Upgrade
Free Cash Flow
-30.35-19.57-41.013.46-29.41-9.81
Upgrade
Free Cash Flow Per Share
-1.13-0.73-1.530.13-1.49-24.58
Upgrade
Gross Margin
--104.89%-100.00%100.00%-
Upgrade
Operating Margin
-628.16%-215.26%-641.07%-179.66%-815.20%-391.59%
Upgrade
Profit Margin
-560.82%-209.60%-618.57%-164.55%-791.68%-425.06%
Upgrade
Free Cash Flow Margin
-608.14%-163.30%-605.91%17.82%-549.74%-261.78%
Upgrade
EBITDA
-30.92-25.33-42.78-34.33-43.28-14.46
Upgrade
EBITDA Margin
--211.37%--177.06%--
Upgrade
D&A For EBITDA
0.430.470.610.50.330.21
Upgrade
EBIT
-31.35-25.79-43.39-34.84-43.61-14.67
Upgrade
EBIT Margin
--215.26%--179.66%--
Upgrade
Revenue as Reported
4.9911.986.77--3.75
Upgrade
Updated May 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q